Chicago Partners Investment Group LLC Increases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Chicago Partners Investment Group LLC has significantly increased its stake in the iShares Biotechnology ETF (NASDAQ:IBB) by 45.8% during the third quarter, as reported in its recent Form 13F filing with the Securities and Exchange Commission. After acquiring an additional 1,159 shares during this period, the institutional investor now owns a total of 3,689 shares. The value of these holdings in iShares Biotechnology ETF is approximately $524,000 at the conclusion of the latest reporting period.

Other notable institutional investors have also adjusted their positions in the iShares Biotechnology ETF. For instance, Highline Wealth Partners LLC bought a new stake worth around $30,000 in the third quarter. Similarly, Bbjs Financial Advisors LLC acquired a new position valued at about $31,000 during the second quarter. Voisard Asset Management Group Inc. also joined the ranks of investors by purchasing shares worth approximately $59,000 in the third quarter. Chris Bulman Inc. invested about $64,000 in the second quarter, while Eastern Bank bought new shares valued at approximately $65,000 in the third quarter. Currently, it is reported that hedge funds and other institutional investors collectively own 62.45% of iShares Biotechnology ETF's stock.

iShares Biotechnology ETF Performance

On Tuesday, shares of iShares Biotechnology ETF traded at $142.85. The ETF exhibits a 50-day moving average of $145.02 and a 200-day moving average of $140.57. Over the past year, the ETF reached a 12-month low of $113.56 and a high of $150.57.

Dividend Details of iShares Biotechnology ETF

In addition to the stock performance, the iShares Biotechnology ETF also declared a dividend recently. This dividend was paid on Monday, September 30th, with a value of $0.2005 per share distributed to investors recorded on Wednesday, September 25th. The ex-dividend date was the same day.

Overview of iShares Biotechnology ETF

The iShares Nasdaq Biotechnology ETF, previously known as the iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund that aims to provide investment results that generally correspond to the price and yield performance of the NASDAQ Biotechnology Index. This Index includes securities from NASDAQ-listed companies that are categorized under biotechnology or pharmaceuticals according to the Industry Classification Benchmark, as well as other eligibility criteria set by NASDAQ.

investment, ETF, biotechnology